Total Payments
$198.73
2024 Payments
$20.00
Companies
7
Transactions
11
Medicare Patients
2,987
Medicare Billing
$379,489
Payment Breakdown by Category
Food & Beverage$198.73 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $198.73 | 11 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $58.72 | 3 | $0 (2022) |
| Allergan, Inc. | $49.84 | 2 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $26.64 | 2 | $0 (2023) |
| Exact Sciences Corporation | $20.00 | 1 | $0 (2024) |
| GlaxoSmithKline, LLC. | $16.62 | 1 | $0 (2017) |
| Amarin Pharma Inc. | $14.16 | 1 | $0 (2020) |
| Lilly USA, LLC | $12.75 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $20.00 | 1 | Exact Sciences Corporation ($20.00) |
| 2023 | $26.64 | 2 | AstraZeneca Pharmaceuticals LP ($26.64) |
| 2022 | $24.44 | 1 | Merck Sharp & Dohme LLC ($24.44) |
| 2021 | $15.46 | 1 | Allergan, Inc. ($15.46) |
| 2020 | $31.93 | 2 | Merck Sharp & Dohme Corporation ($17.77) |
| 2018 | $47.13 | 2 | Allergan Inc. ($34.38) |
| 2017 | $33.13 | 2 | GlaxoSmithKline, LLC. ($16.62) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/20/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Oncology | ||||||
| 05/19/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/23/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/30/2022 | Merck Sharp & Dohme LLC | BELSOMRA (Drug), VERQUVO, STEGLATRO | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: NEUROSCIENCE | ||||||
| 05/05/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: FACIAL AESTHETICS | ||||||
| 08/19/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Cardiovascular | ||||||
| 07/23/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, JANUMET | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/03/2018 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: Diabetes | ||||||
| 01/13/2018 | Allergan Inc. | RHOFADE (Drug) | Food and Beverage | In-kind items and services | $34.38 | General |
| Category: DERMATOLOGY | ||||||
| 10/11/2017 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: NEUROSCIENCE | ||||||
| 02/22/2017 | GlaxoSmithKline, LLC. | ANORO (Drug), INCRUSE | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 626 | 1,512 | $301,937 | $90,193 |
| 2022 | 17 | 551 | 1,479 | $247,545 | $83,822 |
| 2021 | 20 | 849 | 1,847 | $323,267 | $107,202 |
| 2020 | 21 | 961 | 1,786 | $373,341 | $98,272 |
Total Patients
2,987
Total Services
6,624
Medicare Billing
$379,489
Procedure Codes
75
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 133 | 506 | $113,900 | $43,358 | 38.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 77 | 170 | $27,200 | $10,047 | 36.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 64 | 64 | $11,200 | $8,047 | 71.8% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 74 | 79 | $60,593 | $7,017 | 11.6% |
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 30 | 30 | $33,900 | $4,258 | 12.6% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 14 | 28 | $6,366 | $3,285 | 51.6% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 39 | 304 | $4,899 | $2,358 | 48.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 18 | $5,490 | $2,339 | 42.6% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 11 | 16 | $8,000 | $2,104 | 26.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $7,140 | $1,735 | 24.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 11 | 26 | $12,324 | $1,627 | 13.2% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 15 | 25 | $3,500 | $1,124 | 32.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 18 | 24 | $2,400 | $921.48 | 38.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 17 | 75 | $1,875 | $755.76 | 40.3% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 22 | 48 | $1,200 | $698.40 | 58.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 55 | 61 | $1,525 | $512.40 | 33.6% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 11 | 17 | $425.00 | $6.73 | 1.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 129 | 460 | $103,500 | $40,090 | 38.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 91 | 233 | $37,410 | $14,859 | 39.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 50 | 50 | $8,750 | $6,452 | 73.7% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2022 | 16 | 32 | $7,275 | $3,990 | 54.8% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2022 | 41 | 364 | $6,694 | $3,096 | 46.3% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 21 | 22 | $24,860 | $3,050 | 12.3% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 30 | 30 | $23,010 | $2,498 | 10.9% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 11 | 18 | $6,300 | $2,177 | 34.6% |
About Vincent Ivers
Vincent Ivers is a General Practice healthcare provider based in Port St Joe, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1851366702.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Vincent Ivers has received a total of $198.73 in payments from pharmaceutical and medical device companies, with $20.00 received in 2024. These payments were reported across 11 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($198.73).
As a Medicare-enrolled provider, Ivers has provided services to 2,987 Medicare beneficiaries, totaling 6,624 services with total Medicare billing of $379,489. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Ad
Practice Information
- Specialty General Practice
- Location Port St Joe, FL
- Active Since 02/22/2006
- Last Updated 06/17/2019
- Taxonomy Code 208D00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1851366702
Products in Payments
- BELSOMRA (Drug) $40.95
- RHOFADE (Drug) $34.38
- FARXIGA (Drug) $26.64
- Cologuard Collection Kit (Device) $20.00
- JANUVIA (Drug) $17.77
- ANORO (Drug) $16.62
- BOTOX (Biological) $15.46
- Vascepa (Drug) $14.16
- TRULICITY (Drug) $12.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.